I.P López - Department of Biochemistry and Molecular Biology, University of Navarra

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 72 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Trametinib Sensitizes KRAS-mutant Lung Adenocarcinoma Tumors to PD- 1/PD-L1 Axis Blockade Via Id1 Downregulation

Ander Puyalto,María Rodríguez-Remírez,Inés López,Irati Macaya,Elizabeth Guruceaga,María Olmedo,Anna Vilalta-Lacarra,Connor Welch,Sergio Sandiego,Silvestre Vicent,Karmele Valencia,Alfonso Calvo,Ruben Pio,Luis E. Raez,Christian Rolfo,Daniel Ajona,Ignacio Gil-Bazo

MOLECULAR CANCERno. 1 (2024)

引用0浏览0WOS引用

IGF1R Plays a Protective Role in Pneumococcal Pneumonia

M. Felten,L. Teixeira Alves,E. Letsiou,E. Alfaro Arnedo,S. Pineiro-Hermida,I. P. Lopez,K. Dietert,T. C. Firsching,A. D. Gruber, D. Fatykova,A. C. Hocke,T. Lingscheid,J. Lienau,J. G. Pichel,M. Witzenrath

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2024)

引用0浏览0引用

Preclinical Evaluation of RMC-7977, a Multi-Selective RAS(ON) Inhibitor, As a Therapeutic Strategy for KRAS-Mutant

R. Entrialgo Cadierno, I. Feliu,I. Lopez,I. Macaya,Y. Senent, S. Narayanan,N. Nasholm, R. Pio, J. Jiang,S. Vicent

EUROPEAN JOURNAL OF CANCER (2024): S112-S112

引用0浏览0引用

297 (PB285): Preclinical Evaluation of RMC-7977, a Multi-Selective RAS(ON) Inhibitor, As a Therapeutic Strategy for KRAS-Mutant Cholangiocarcinoma

R. Entrialgo Cadierno, I. Feliu,I. Lopez,I. Macaya,Y. Senent, S. Narayanan,N. Nasholm,R. Pio, J. Jiang,S. Vicent

European Journal of Cancer (2024): 114811

引用0浏览0引用

MA12.11 A Novel 89Zr-Anti-pd1 Immunopet-Ct May Predict Response to PD-1 Inhibitors in a Lung Cancer Murine Model Receiving Immunotherapy

A. Puyalto,M. Rodríguez-Remírez,I. López,J.A. Simón,M. Ecay,M. Collantes,A. Vilalta-Lacarra,A. Francisco-Cruz,J.L. Solórzano,I. Peñuelas,D. Ajona,I. Gil-Bazo

Journal of Thoracic Oncology（2023）

引用0浏览0引用

A Novel 89Zr-Anti-pd-1 Immuno-Pet-ct May Predict Response to PD-1 Inhibitors and Improve Response Assessment in a Lung Cancer Murine Model Receiving Immunotherapy

A. Puyalto,M. Rodriguez-Remirez,I. Lopez,J. A. Simon,M. Ecay,M. Collantes,A. Vilalta,A. Francisco-Cruz,J. L. Solorzano,I. Penuelas,D. Ajona,I. Gil Bazo

ANNALS OF ONCOLOGY (2023): S1154-S1155

引用0浏览0引用

2324P Trametinib and PD-1 Combined Blockade Impairs Tumor Growth and Improves Survival of KRAS-mutant Lung Cancer Through Id1 Downregulation

A. Puyalto,M. Rodríguez-Remírez,I. López,M. Olmedo López-Frías,A. Vilalta,I. Macaya,C. Welch,S. Vicent,A. Calvo,D. Ajona,I. Gil Bazo

Annals of Oncology (2023): S1187

引用0浏览0引用

P1.06-02 Trametinib Plus ANTI-PD-1 Immunotherapy Impairs Tumor Growth and Increases Survival of Lung Cancer Through ID1 Downregulation

A. Puyalto,M. Rodríguez-Remírez,I. López,M. Olmedo,A. Vilalta-Lacarra,I. Macaya,C. Welch,A. Calvo,S. Vicent,D. Ajona,I. Gil-Bazo

Journal of Thoracic Oncologyno. 11 (2023): S194

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn